STOCK TITAN

II-VI Incorporated Introduces Diffraction-Limited Apochromatic Objective Lenses for Fluorescence Imaging in Life Sciences

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

II-VI Incorporated (Nasdaq: IIVI), a leader in imaging optics, has launched its new diffraction-limited apochromatic objective lenses for fluorescence imaging. These lenses offer subwavelength surface regularity and high optical transmission, addressing the increasing demand from life sciences instruments like flow cytometers and DNA sequencers. The lenses will support next-generation instrumentation and are manufactured in ISO-certified facilities across the globe. II-VI will present its products at the SPIE BiOS Digital Marketplace from March 6-11, 2021.

Positive
  • Launch of advanced diffraction-limited apochromatic objective lenses for fluorescence imaging.
  • Meets growing demand for precision optics in life sciences instruments.
  • High optical transmission and surface quality enhance imaging capabilities.
  • Global manufacturing footprint with ISO-certified facilities supports high-quality production.
Negative
  • None.

PITTSBURGH, Feb. 10, 2021 (GLOBE NEWSWIRE) -- II‐VI Incorporated (Nasdaq: IIVI), a leading provider of imaging optics, today announced the introduction of its diffraction-limited apochromatic objective lenses for fluorescence imaging.

The rapidly growing number of life sciences instruments, including fluorescence-based imaging systems, flow cytometers, and DNA sequencers, is driving the demand for precision optics that enable greater imaging resolution across the full visible spectrum. II-VI’s new apochromatic objective lenses achieve subwavelength surface regularity and exceptionally high optical transmission to enable diffraction-limited performance, making them well-suited for a broad range of life sciences instrumentation platforms.

“We pushed the limits of precision manufacturing and metrology to achieve diffraction-limited optics that are highly desirable for apochromatic imaging in next-generation fluorescence-based instrumentation platforms,” said Dr. Guanglong Yu, Vice President, Advanced Optics Business Unit. “Now, customers can leverage these leading capabilities, together with our broad portfolio of related components, our rapid turnaround time on custom designs, and our global footprint of ISO-certified life sciences assembly facilities, to realize their next-generation instrumentation platforms, followed by a seamless transfer to high-quality manufacturing at scale.”

II-VI’s broad portfolio of products for instrumentation in life sciences includes visible-wavelength lasers and laser systems, precision optics, filters, and assemblies, as well as thermoelectric modules. System providers can expand assembly manufacturing at II-VI’s facilities in Dallas, Texas; Fuzhou, China; and Ho Chi Minh City, Vietnam, which are certified to ISO 13485 for biomedical assemblies.

II-VI will showcase its broad product line of optics and lasers for life sciences at the 2021 SPIE BiOS Digital Marketplace, March 6-11, 2021.

About II-VI Incorporated

II-VI Incorporated, a global leader in engineered materials and optoelectronic components, is a vertically integrated manufacturing company that develops innovative products for diversified applications in communications, materials processing, aerospace & defense, semiconductor capital equipment, life sciences, consumer electronics, and automotive markets. Headquartered in Saxonburg, Pennsylvania, the Company has research and development, manufacturing, sales, service, and distribution facilities worldwide. The Company produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in various forms, including integrated with advanced software to support our customers. For more information, please visit us at www.ii-vi.com.

  
CONTACT:Mark Lourie
 Vice President, Corporate Communications
 corporate.communications@ii-vi.com
 www.ii-vi.com/contact-us


FAQ

What are the new products introduced by II-VI on February 10, 2021?

II-VI introduced diffraction-limited apochromatic objective lenses for fluorescence imaging.

How do II-VI's new lenses improve life sciences instrumentation?

The lenses offer subwavelength surface regularity and high optical transmission, enhancing imaging resolution.

Where can I see II-VI's products showcased?

II-VI will showcase its product line at the SPIE BiOS Digital Marketplace from March 6-11, 2021.

What is the significance of ISO certification for II-VI's manufacturing facilities?

ISO certification ensures high-quality and reliable production standards for biomedical assemblies.

What companies are involved in the life sciences instrumentation market?

II-VI provides precision optics and components needed for various life sciences instruments.

IIVI

NYSE:IIVI

IIVI Rankings

IIVI Latest News

IIVI Stock Data

Optical Instrument and Lens Manufacturing
Manufacturing
Link
US
Saxonburg